Teva Pharmaceutical

$7.01
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.21 (-2.89%) Today
-$0.04 (-0.57%) As of 7:06 PM EDT after-hours

Why Robinhood?

You can buy or sell TEVA and other stocks, options, ETFs, and crypto commission-free!

About TEVA

Teva Pharmaceutical Industries Limited American Depositary Shares, also called Teva Pharmaceutical, is a global pharmaceutical company, which engages in development, production and marketing of drugs, generic drugs, over-the-counter drugs, active ingredients for the pharmaceutical industry (APIs) and therapeutic products. It operates through two segments: Generic Medicines and Specialty Medicines. Read More The Generic Medicines segment includes chemical and therapeutic equivalents of originator medicines in a variety of dosage forms, including tablets, capsules, injectables, inhalants, liquids, ointments and creams. The Specialty Medicine segment engages in the provision of core therapeutic areas of central nervous system medicines. The company was founded in 1901 and is headquartered in Petach Tikva, Israel.

Employees
42,535
Headquarters
Petach Tikva, HaMerkaz
Founded
1901
Market Cap
7.94B
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
22.17M
High Today
$7.38
Low Today
$7.02
Open Price
$7.22
Volume
15.30M
52 Week High
$25.13
52 Week Low
$6.07

Collections

TEVA News

BenzingaAug 22

Jim Cramer Weighs In On Pfizer, Teva And More

716
MarketWatchAug 21

Shares of Teva up 3% on positive migraine trial

695
Financial PostAug 20

Teva launches generic version of EpiPen for young children

288

TEVA Earnings

$0.53
$0.67
$0.80
$0.94
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
Actual
Expected Oct 31, Pre-Market

Popular Stocks

More TEVA News

MarketWatchAug 20

Teva says FDA-approved generic EpiPen is now available in the U.S. for $300 for a 2-pack

790
ReutersAug 15

Teva settles multibillion-dollar drug kickback case ahead of trial

1,391
Barron'sAug 15

Drug Stocks Sank After 2 Members of Congress Reopened a Price-Fixing Inquiry

1,264
ReutersAug 14

Judge certifies Niaspan 'pay-for-delay' class action against AbbVie, Teva

50
CNBCAug 14

Bernie Sanders, Elijah Cummings accuse drugmakers Mylan and Teva of 'coordinated obstruction'

132
BloombergAug 14

Generic-Drug Giants Accused of Blocking Congressional Probe

1,247
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.